Literature DB >> 10780261

Memory restoring and neuroprotective effects of the proline-containing dipeptide, GVS-111, in a photochemical stroke model.

R U Ostrovskaya1, G A Romanova, I V Barskov, E V Shanina, T A Gudasheva, I V Victorov, T A Voronina, S B Seredenin.   

Abstract

Local thrombosis of the frontal cortex (Fr1 and Fr3 fields), caused by combination of the intravenous photosensitive dye Rose Bengal administration with focused high-intensity illumination of the frontal bone, was shown to provoke a pronounced deficit in step-through passive avoidance performance in rats without concomitant motor disturbances. N-Phenylacetyl-L-prolylglycine ethyl ester (GVS-111) administered intravenously at a dose of 0.5 mg/kg/day, for the first time 1 h after ischaemic lesion and then for 9 post-operative days, with the last administration 15 min before testing, attenuated the deficit. This treatment significantly diminished the volume of the infarcted area. Thus, post-ischaemic injection of GVS-111 demonstrated both cognition-restoring and neuroprotective properties. The cognition-restoring effect is probably based on an increase in neocortical and hippocampal neuronal plasticity. Neuroprotective effects of GVS-111 combine antioxidant activity with the ability to attenuate glutamate-provoked neurotoxicity and block voltage-gated ionic channels, i.e. the compound mitigates the main metabolic shifts involved in pathogenesis of brain ischaemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10780261     DOI: 10.1097/00008877-199909000-00013

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  6 in total

1.  Formation of spatial memory in rats with ischemic lesions to the prefrontal cortex; effects of a synthetic analog of ACTH(4-7).

Authors:  D N Silachev; S I Shram; F M Shakova; G A Romanova; N F Myasoedov
Journal:  Neurosci Behav Physiol       Date:  2009-09-23

2.  RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).

Authors:  Shimin Liu; Gehua Zhen; Bruno P Meloni; Kym Campbell; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2009-01-01

3.  Noopept; a nootropic dipeptide, modulates persistent inflammation by effecting spinal microglia dependent Brain Derived Neurotropic Factor (BDNF) and pro-BDNF expression throughout apoptotic process.

Authors:  Mona Taghizadeh; Nader Maghsoudi; Homa Manaheji; Valery Akparov; Mansoureh Baniasadi; Mola Mohammadi; Samira Danyali; Rasoul Ghasemi; Jalal Zaringhalam
Journal:  Heliyon       Date:  2021-02-12

4.  Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation.

Authors:  Rita U Ostrovskaya; Yulia V Vakhitova; Uliyana Sh Kuzmina; Milyausha Kh Salimgareeva; Liana F Zainullina; Tatiana A Gudasheva; Vener A Vakhitov; Sergey B Seredenin
Journal:  J Biomed Sci       Date:  2014-08-06       Impact factor: 8.410

5.  Molecular Mechanism Underlying the Action of Substituted Pro-Gly Dipeptide Noopept.

Authors:  Y V Vakhitova; S V Sadovnikov; S S Borisevich; R U Ostrovskaya; T A Gudasheva; S B Seredenin
Journal:  Acta Naturae       Date:  2016 Jan-Mar       Impact factor: 1.845

Review 6.  Novel Technologies for Dipeptide Drugs Design and their Implantation.

Authors:  Tatiana A Gudasheva; Rita U Ostrovskaya; Sergey B Seredenin
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.